Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 24, 2015

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions

Plasma Cell LeukemiaPlasma Cell MyelomaPlasmacytoma

Interventions

DRUG

Dexamethasone

Given PO

DRUG

Ixazomib Citrate

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Pomalidomide

Given PO

Trial Locations (2)

Sarah Cannon Cancer Center, Nashville

Mayo Clinic, Rochester